US EditionThe Government Repealed a 2012 Resolution to Facilitate the Granting of New Patents on Medicines
14 Articles
14 Articles
A Kirchnerism rule that provided for restrictions on the patenting of pharmaceutical products was rendered ineffective. There will be no change for products that are already on the market
Federico Sturzenegger, the Minister of Deregulation and Transformation of the State of the Argentine Nation, spoke, in a post of his X account, about deregulation to facilitate patents of Argentine medicines. “As it is in any country of the world, from today the National Institute of Industrial Property (INPI) will analyze each patent application case by case, according to the law, without additional restrictions that do not exist in any country…
Writing Open Channel Joint Resolution 1/2026 of the Ministry of Health, Ministry of Economy and National Institute of Industrial Property (INPI) repealed a previous resolution, in 2012, providing that “the National Institute of Industrial Property shall determine in each case the origin of the patentability of chemical-pharmaceutical inventions according to Law No. 24481 and its modifications”.
The government amended the regulation on patents for medicines and established a system that gives the National Institute of Intellectual Property (INPI) the power to analyze each patent. The measure affects generic medicines. Joint resolution 1/26 repealed resolution 118/2012 on pharmaceutical patents and with it the requirements to process patents, replacing it with a case-by-case review by INPI, following the conditions that apply to patent o…
“Argentina returns to the world.” With these triumphalist terms, the Minister of Deregulation, Federico Sturzenegger, referred to Joint Resolution 1/26 published today in the Official Gazette amending the Medical Patent Law, an old longing of international laboratories. The measure, which was claimed by the Secretary of the Treasury of the United States, Scot Bessent, on his visit to Argentina, carries the signature of the Ministers of Health, M…
Canal C Pharmaceutical Patents: the government changes the rules of the game The national government formalized a easing of the granting of pharmaceutical patents through Joint Resolution 1/2026, signed by the Ministries of Health and Economics together with INPI. The measure, published on March 18 in the Official Gazette, removes the restrictions in force since 2012 and redefines the evaluation system. From now on, the National Institute of Ind…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
